aod9604 and semaglutide AOD-9604 vs MOTS-c vs Tesamorelin vs vs Tirzepatide: Which Is Best for Weight Loss Metabolic Health? AOD-9604 vs Semaglutide: Peptide Key
Description
In this article, Abba Kastin and colleagues review the known effects of DSIP and argue that further work is needed before it can be considered functional
Drug Delivery And Translational Research
Exploring NNMT: from metabolic pathways to therapeutic targets
Yes (strong) FDA status FDA-approved (T2D and obesity) Compound NAD+ (intravenous or subcutaneous) Mechanism Direct NAD+ supplementation Route IV infusion or subcutaneous Acts on appetite
Development of a pharmacologically improved peptide agonist of the leptin receptor
AOD-9604 lacks this broad receptor engagement, confining its research activity to lipolytic pathways, which makes it a more targeted and mechanistically distinct compound for metabolic research models
